Filing Details

Accession Number:
0001179110-18-011611
Form Type:
4
Zero Holdings:
No
Publication Time:
2018-09-21 17:02:14
Reporting Period:
2018-09-20
Accepted Time:
2018-09-21 17:02:14
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1800 Abbott Laboratories ABT Pharmaceutical Preparations (2834) 360698440
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1492289 J Brian Blaser 100 Abbott Park Road
Abbott Park IL 60064-6400
Executive Vice President No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Shares Without Par Value Acquisiton 2018-09-20 48,100 $27.03 184,918 No 4 M Direct
Common Shares Without Par Value Acquisiton 2018-09-20 10,100 $29.29 195,018 No 4 M Direct
Common Shares Without Par Value Disposition 2018-09-20 900 $68.73 194,118 No 4 S Direct
Common Shares Without Par Value Disposition 2018-09-20 350 $68.74 193,768 No 4 S Direct
Common Shares Without Par Value Disposition 2018-09-20 100 $68.74 193,668 No 4 S Direct
Common Shares Without Par Value Disposition 2018-09-20 1,800 $68.74 191,868 No 4 S Direct
Common Shares Without Par Value Disposition 2018-09-20 1,250 $68.75 190,618 No 4 S Direct
Common Shares Without Par Value Disposition 2018-09-20 800 $68.75 189,818 No 4 S Direct
Common Shares Without Par Value Disposition 2018-09-20 2,043 $68.76 187,775 No 4 S Direct
Common Shares Without Par Value Disposition 2018-09-20 1,757 $68.76 186,018 No 4 S Direct
Common Shares Without Par Value Disposition 2018-09-20 1,837 $68.77 184,181 No 4 S Direct
Common Shares Without Par Value Disposition 2018-09-20 3,020 $68.77 181,161 No 4 S Direct
Common Shares Without Par Value Disposition 2018-09-20 3,822 $68.78 177,339 No 4 S Direct
Common Shares Without Par Value Disposition 2018-09-20 2,400 $68.78 174,939 No 4 S Direct
Common Shares Without Par Value Disposition 2018-09-20 2,300 $68.79 172,639 No 4 S Direct
Common Shares Without Par Value Disposition 2018-09-20 7,807 $68.79 164,832 No 4 S Direct
Common Shares Without Par Value Disposition 2018-09-20 1,100 $68.80 163,732 No 4 S Direct
Common Shares Without Par Value Disposition 2018-09-20 1,500 $68.80 162,232 No 4 S Direct
Common Shares Without Par Value Disposition 2018-09-20 1,442 $68.81 160,790 No 4 S Direct
Common Shares Without Par Value Disposition 2018-09-20 4,522 $68.81 156,268 No 4 S Direct
Common Shares Without Par Value Disposition 2018-09-20 1,136 $68.82 155,132 No 4 S Direct
Common Shares Without Par Value Disposition 2018-09-20 5,800 $68.82 149,332 No 4 S Direct
Common Shares Without Par Value Disposition 2018-09-20 2,000 $68.83 147,332 No 4 S Direct
Common Shares Without Par Value Disposition 2018-09-20 6,240 $68.83 141,092 No 4 S Direct
Common Shares Without Par Value Disposition 2018-09-20 960 $68.84 140,132 No 4 S Direct
Common Shares Without Par Value Disposition 2018-09-20 3,214 $68.84 136,918 No 4 S Direct
Common Shares Without Par Value Disposition 2018-09-20 100 $68.85 136,818 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 M Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Shares Option (right to buy) Disposition 2018-09-20 48,100 $0.00 48,100 $27.03
Common Shares Option (right to buy) Disposition 2018-09-20 10,100 $0.00 10,100 $29.29
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2015-02-17 2022-02-16 No 4 M Direct
0 2015-06-01 2022-05-31 No 4 M Direct
Footnotes
  1. Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program, in a transaction exempt from Section 16 under Rule 16b-3.